Prostate Cancer

Second-Generation Antiandrogens Linked to Falls, Cognitive Toxicity in Prostate Cancer Patients

By

Leah Lawrence

Publish Date June 2, 2023

Prostate cancer patients treated with second-generation antiandrogens may have an increased risk of falls, fatigue, and cognitive toxicity.

Cancer Death Rates Vary Across Congressional Districts

By

Leah Lawrence

Publish Date May 24, 2023

Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.

Enzalutamide Ups Metastasis-Free Survival in nmHSPC

By

Jody A. Charnow

Publish Date May 10, 2023

Investigators report results from the phase 3 randomized EMBARK trial.

Transgender Women May Be Underdiagnosed With Prostate Cancer

Publish Date May 9, 2023

Findings suggest link to more aggressive disease among estrogen users, but researchers say larger studies needed.

Prostate Cancer Hits Patients With Substantial Out-of-Pocket Expenses

By

Jody A. Charnow

Publish Date May 8, 2023

Investigators analyzed survey results from 495 patients with newly diagnosed localized prostate cancer.

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets